John M. Dineen - Insider Trading & Ownership

Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Summary
The estimated net worth of John M. Dineen is at least $872K dollars as of August 28, 2025. John M. Dineen is the Director of LAM RESEARCH CORP and owns shares of LAM RESEARCH CORP (LRCX) stock worth about $564K. John M. Dineen is the Director of COGNIZANT TECHNOLOGY SOLUTIONS CORP and owns shares of COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) stock worth about $309K.
Signature
/s/ Kelli Arman, on behalf of John M. Dineen, by Power of Attorney
All Insider Reports
All Insider Reports

Ownership of John M. Dineen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LRCX LAM RESEARCH CORP Director $564K Nov 8, 2024
CTSH COGNIZANT TECHNOLOGY SOLUTIONS CORP Director $309K Aug 26, 2025
SYNH Syneos Health, Inc. Director Sep 28, 2023

Insider Transactions Reported by John M. Dineen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.